Results of an innovative clinical trial led by Perth researchers have shown that the drug interferon could help reduce the spread of COVID-19 from a positive person to their household contacts, with ...

May 15 (UPI) --Treatment with the hepatitis drug interferon-alpha-2b might speed recovery for people with COVID-19, a small study published Friday by the journal Frontiers in Immunology found.

(Tuesday, March 21, 2017 -- Toronto) -- A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola ...

Interferons are a category of organically rising enzymes that are created by nucleus less cells and mainly exhibit activities alongside viral inflammations and other organic inducers. The three main ...

A new drug quashes all coronavirus variants. But regulatory hurdles and a lack of funding make it unlikely to reach the U.S. market anytime soon. By Benjamin Mueller Over the past year, America’s ...

A one-time shot with an experimental drug halved COVID-19 patients' risk of being hospitalized with the illness compared with a placebo, a late-stage trial shows. However, the treatment may still be ...

This is the crystal structure of human STING, bond with a synthetic a drug currently in clinical trials for cancer. The same drug stops SARS-Cov-2 from infecting and killing susceptible animals, and I ...

Interferon therapies are well established as treatment options for some types of cancer, but they have not been used to treat cancers characterized by the overproduction of blood cells. The FDA has ...

Almost all cases of chronic liver disease caused by the hepatitis C virus -- the most common reason for liver transplants -- probably could be prevented if people were given the antiviral drug ...

A small study of an inhaled form of a commonly available drug, interferon beta, suggests it could reduce the odds of patients becoming severely ill. By Benjamin Mueller LONDON — A British drug company ...

When the worldwide death toll from Covid-19 surpassed five million two weeks ago, it served as a grim reminder that more than lockdowns and vaccines will be needed to end the pandemic. A new study, ...